Blog & News

The U.S. Congress has just approved the Food and Drug Administration’s (FDA) new accelerated approval path. Accelerated approvals allow the agency to pass fast access…

There is still plenty of cash looking for a good home, but the criteria have changed. It’s no longer enough to have a good idea…

Thanks to its role in developing products and services that improve public health, the life sciences industry provides the purpose that is seen as so…

As 2023 swings into gear, Talentmark are already out and about getting the inside-track on the key issues facing the life sciences industry. David Nolan…

Why is it that so many life-sciences firms don't use an executive search partner as an integral part of developing and delivering their growth strategy?…

It has been exciting to be on the ground at this year’s Cell & Gene Meeting on the Mesa in California and to hear about…

In mid May, leaders from the life sciences industry gathered in London for the annual Life Science eXecutives (LSX) World Congress. Now in its ninth…

When it comes to interim management and life sciences what was once a niche stop-gap activity now plays a key part in providing organisations with…

In the spring of 2021, Marja Halma began working at Centrafarm with the responsibility for placing a new Parkinson’s medication on the Dutch market. Despite…

In medicine, cell and gene treatments are currently one of the most active areas of study and investment. Because of the recent success of numerous…

Boardroom performance and board composition are integrally related.  If you don’t pay attention to its formation and know what you want, you may end up…

A talent shortage is a problem for all industries, but particularly acute in the Life Sciences industry with a record number of job openings and…